Mount Sinai Health System and Renalytix form joint venture, Kantaro Biosciences, to develop and scale production of COVID antibody test kits

(The Mount Sinai Hospital / Mount Sinai School of Medicine) Kantaro Biosciences partners with Bio-Techne for manufacturing and global kit distribution. Scaled kit production to enable clinical laboratories to conduct 10M tests per month beginning July 2020.